These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8928608)

  • 1. Basement membrane abnormality in merosin-negative congenital muscular dystrophy.
    Osari S; Kobayashi O; Yamashita Y; Matsuishi T; Goto M; Tanabe Y; Migita T; Nonaka I
    Acta Neuropathol; 1996; 91(4):332-6. PubMed ID: 8928608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of muscle basal lamina in congenital muscular dystrophy with merosin deficiency.
    Minetti C; Bado M; Morreale G; Pedemonte M; Cordone G
    Neurology; 1996 May; 46(5):1354-8. PubMed ID: 8628482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electron microscopic examination of basal lamina in Fukuyama congenital muscular dystrophy.
    Ishii H; Hayashi YK; Nonaka I; Arahata K
    Neuromuscul Disord; 1997 May; 7(3):191-7. PubMed ID: 9185184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and histopathological study of merosin-deficient and merosin-positive congenital muscular dystrophy.
    Talim B; Kale G; Topaloglu H; Akçören Z; Caglar M; Gögüş S; Elkay M
    Pediatr Dev Pathol; 2000; 3(2):168-76. PubMed ID: 10679036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unexpected sarcolemmal complement membrane attack complex deposits on nonnecrotic muscle fibers in muscular dystrophies.
    Spuler S; Engel AG
    Neurology; 1998 Jan; 50(1):41-6. PubMed ID: 9443455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical study of merosin-negative congenital muscular dystrophy: laminin alpha 2 deficiency in skin biopsy.
    Marbini A; Bellanova MF; Ferrari A; Lodesani M; Gemignani F
    Acta Neuropathol; 1997 Aug; 94(2):103-8. PubMed ID: 9255383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Muscular dystrophies due to alterations at extracellular space level: congenital muscular dystrophy caused by merosin deficiency].
    Smeyers P
    Rev Neurol; 1999 Jan 16-31; 28(2):141-9. PubMed ID: 10101782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Massive muscle cell degeneration in the early stage of merosin-deficient congenital muscular dystrophy.
    Hayashi YK; Tezak Z; Momoi T; Nonaka I; Garcia CA; Hoffman EP; Arahata K
    Neuromuscul Disord; 2001 May; 11(4):350-9. PubMed ID: 11369186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital muscular dystrophy: Clinical and pathologic study of 50 patients with the classical (Occidental) merosin-positive form.
    Kobayashi O; Hayashi Y; Arahata K; Ozawa E; Nonaka I
    Neurology; 1996 Mar; 46(3):815-8. PubMed ID: 8618689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal lamina abnormality in the skeletal muscle of Walker-Warburg syndrome.
    Vajsar J; Ackerley C; Chitayat D; Becker LE
    Pediatr Neurol; 2000 Feb; 22(2):139-43. PubMed ID: 10738921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-Fukuyama type merosin-positive congenital muscular dystrophy with delayed muscle fiber type differentiation: a case report].
    Korematsu S; Kobayashi O; Fukushima N; Sawaguchi H; Ishihara T; Izumi T; Ogawa T; Nonaka I
    No To Hattatsu; 1995 Jul; 27(4):309-14. PubMed ID: 7612293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Merosin-negative congenital muscular dystrophy associated with extensive brain abnormalities.
    Sunada Y; Edgar TS; Lotz BP; Rust RS; Campbell KP
    Neurology; 1995 Nov; 45(11):2084-9. PubMed ID: 7501163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital muscular dystrophy: use of brain MR imaging findings to predict merosin deficiency.
    Lamer S; Carlier RY; Pinard JM; Mompoint D; Bagard C; Burdairon E; Estournet B; Barois A; Vallée C
    Radiology; 1998 Mar; 206(3):811-6. PubMed ID: 9494506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of laminin beta 2 chain expression in congenital muscular dystrophy.
    Cohn RD; Herrmann R; Wewer UM; Voit T
    Neuromuscul Disord; 1997 Sep; 7(6-7):373-8. PubMed ID: 9327401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Merosin (laminin-2) localization in basal lamina of normal skeletal muscle fibers and changes in plasma membrane of merosin-deficient skeletal muscle fibers.
    Shibuya S; Wakayama Y; Inoue M; Kojima H; Oniki H
    Med Electron Microsc; 2003 Dec; 36(4):213-20. PubMed ID: 16228654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of laminin chains in skin in merosin-deficient congenital muscular dystrophy.
    Sewry CA; D'Alessandro M; Wilson LA; Sorokin LM; Naom I; Bruno S; Ferlini A; Dubowitz V; Muntoni F
    Neuropediatrics; 1997 Aug; 28(4):217-22. PubMed ID: 9309712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis of congenital muscular dystrophy and clinical significance of merosin expression].
    Xiong H; Yao S; Yuan Y; Chang XZ; Wu Y; Bao XH; Zhang YH; Wu HS; Chen L; Qin J; Wu XR
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):918-23. PubMed ID: 17254461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiency of a skeletal muscle isoform of alpha-actinin (alpha-actinin-3) in merosin-positive congenital muscular dystrophy.
    North KN; Beggs AH
    Neuromuscul Disord; 1996 Aug; 6(4):229-35. PubMed ID: 8887951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital muscular dystrophy syndromes distinguished by alkaline and acid phosphatase, merosin, and dystrophin staining.
    Connolly AM; Pestronk A; Planer GJ; Yue J; Mehta S; Choksi R
    Neurology; 1996 Mar; 46(3):810-14. PubMed ID: 8618688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular genetics and merosin abnormality in Fukuyama-type congenital muscular dystrophy (FCMD)].
    Toda T; Kobayashi K
    Nihon Rinsho; 1997 Dec; 55(12):3169-75. PubMed ID: 9436430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.